Iguana Healthcare Management’s Intersect ENT, Inc XENT Stock Holding History

Iguana Healthcare Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-75,000	Closed	-$2.43M	–	79
2017 Q4	$2.43M	Sell	75,000 -15,000	-17%	-$450K	1.58%	23
2017 Q3	$2.8M	Buy	90,000 +20,000	+29%	+$592K	1.53%	28
2017 Q2	$1.96M	Sell	70,000 -30,000	-30%	-$679K	1.11%	36
2017 Q1	$1.72M	Buy	100,000 +25,000	+33%	+$350K	0.85%	40
2016 Q4	$908K	Sell	75,000 -105,000	-58%	-$1.36M	0.54%	44
2016 Q3	$2.85M	Buy	180,000 +30,000	+20%	+$452K	0.51%	54
2016 Q2	$1.94M	Buy	+150,000	New	+$2.35M	0.79%	41

Other funds holding XENT

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Iguana Healthcare Management's XENT Position: Q1 2018 in Review

Iguana Healthcare Management sold out of Intersect ENT, Inc (XENT) in Q1 2018, closing a stake of 75,000 shares — an estimated $2.43M sold.

Iguana Healthcare Management first reported a position in XENT in Q2 2016 and held it in 7 quarters. The position peaked at $2.85M in Q3 2016. 172 funds tracked by Wall St. Rank hold XENT as of Q1 2018.

Iguana Healthcare Management reported no remaining Intersect ENT, Inc position as of Q1 2018 after selling out during the quarter.
Iguana Healthcare Management sold 75,000 Intersect ENT, Inc shares in Q1 2018, an estimated $2.43M.
Iguana Healthcare Management first reported a position in Intersect ENT, Inc in Q2 2016 and held it in 7 quarters.
Iguana Healthcare Management's Intersect ENT, Inc position peaked at $2.85M in Q3 2016.
172 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.